Skip to main content

Medications for Breast Cancer

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Herceptin Hylecta 10 1 review for Herceptin Hylecta to treat Breast Cancer Rx N
Generic name:
hyaluronidase / trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
hyaluronidase / trastuzumab 10 1 review for hyaluronidase / trastuzumab to treat Breast Cancer Rx N
Generic name:
hyaluronidase / trastuzumab systemic
Brand name:
Herceptin Hylecta
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
Abraxane 9.7 3 reviews for Abraxane to treat Breast Cancer Rx D N
Generic name:
paclitaxel protein-bound systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
paclitaxel protein-bound 9.7 3 reviews for paclitaxel protein-bound to treat Breast Cancer Rx D N
Generic name:
paclitaxel protein-bound systemic
Brand name:
Abraxane
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
Enhertu 8.5 4 reviews for Enhertu to treat Breast Cancer Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
fam-trastuzumab deruxtecan 8.5 4 reviews for fam-trastuzumab deruxtecan to treat Breast Cancer Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Brand name:
Enhertu
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Kisqali 8.3 3 reviews for Kisqali to treat Breast Cancer Rx N
Generic name:
ribociclib systemic
Drug class:
CDK 4/6 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Herceptin 8.2 5 reviews for Herceptin to treat Breast Cancer Rx D N
Generic name:
trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
trastuzumab 8.2 5 reviews for trastuzumab to treat Breast Cancer Rx D N
Generic name:
trastuzumab systemic
Brand names:
Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera, Hercessi
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
hyaluronidase / pertuzumab / trastuzumab 8.0 1 review for hyaluronidase / pertuzumab / trastuzumab to treat Breast Cancer Rx N
Generic name:
hyaluronidase / pertuzumab / trastuzumab systemic
Brand name:
Phesgo
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Phesgo 8.0 1 review for Phesgo to treat Breast Cancer Rx N
Generic name:
hyaluronidase / pertuzumab / trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
toremifene 8.0 2 reviews for toremifene to treat Breast Cancer Rx D N
Generic name:
toremifene systemic
Drug class:
hormones/antineoplastics, selective estrogen receptor modulators
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Verzenio 8.0 35 reviews for Verzenio to treat Breast Cancer Rx N
Generic name:
abemaciclib systemic
Drug class:
CDK 4/6 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
abemaciclib 7.9 39 reviews for abemaciclib to treat Breast Cancer Rx N
Generic name:
abemaciclib systemic
Brand name:
Verzenio
Drug class:
CDK 4/6 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
alpelisib 7.4 5 reviews for alpelisib to treat Breast Cancer Rx N
Generic name:
alpelisib systemic
Brand name:
Piqray
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Piqray 7.4 5 reviews for Piqray to treat Breast Cancer Rx N
Generic name:
alpelisib systemic
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
sacituzumab govitecan 7.4 5 reviews for sacituzumab govitecan to treat Breast Cancer Rx N
Generic name:
sacituzumab govitecan systemic
Brand name:
Trodelvy
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
ribociclib 7.2 5 reviews for ribociclib to treat Breast Cancer Rx N
Generic name:
ribociclib systemic
Brand name:
Kisqali
Drug class:
CDK 4/6 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
letrozole / ribociclib 7.0 1 review for letrozole / ribociclib to treat Breast Cancer Rx N
Generic name:
letrozole / ribociclib systemic
Brand name:
Kisqali Femara Co-Pack
Drug class:
antineoplastic combinations
For consumers:
dosage, interactions, side effects
paclitaxel 7.0 2 reviews for paclitaxel to treat Breast Cancer Rx D N
Generic name:
paclitaxel systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Trodelvy 6.8 4 reviews for Trodelvy to treat Breast Cancer Rx N
Generic name:
sacituzumab govitecan systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Xeloda 6.6 5 reviews for Xeloda to treat Breast Cancer Rx D N
Generic name:
capecitabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
capecitabine 6.5 10 reviews for capecitabine to treat Breast Cancer Rx D N
Generic name:
capecitabine systemic
Brand name:
Xeloda
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Keytruda 6.3 14 reviews for Keytruda to treat Breast Cancer Rx D N
Generic name:
pembrolizumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Femara 6.2 38 reviews for Femara to treat Breast Cancer Rx D N
Generic name:
letrozole systemic
Drug class:
hormones/antineoplastics, aromatase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Breast Cancer

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.